Long term non-selective and cardioselective beta-receptor blockade in hypertensive patients. Effects on circulatory parameters, catecholamines and renin activity under basal conditions and in connection with exercise and hypoglycemia.
D000319:Adrenergic beta-Antagonists / Q000009:adverse effects / Q000627:therapeutic use*; D000328:Adult; D000368:Aged; D000450:Aldosterone / Q000652:urine; D001786:Blood Glucose / Q000032:analysis; D001794:Blood Pressure / Q000187:drug effects; D002986:Clinical Trials as Topic; D003517:Cyclopentanes / Q000627:therapeutic use; D004341:Drug Evaluation; D004837:Epinephrine / Q000378:metabolism; D005260:Female; D006801:Humans; D006973:Hypertension / Q000188:drug therapy*; D008297:Male; D008790:Metoprolol / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use; D008875:Middle Aged; D009638:Norepinephrine / Q000378:metabolism; D005082:Physical Exertion; D011412:Propanolamines / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use; D011674:Pulse / Q000187:drug effects; D011943:Receptors, Adrenergic, beta / Q000187:drug effects; D012083:Renin / Q000097:blood; D013997:Time Factors
D000319:Adrenergic beta-Antagonists; D001786:Blood Glucose; D003517:Cyclopentanes; D011412:Propanolamines; D011943:Receptors, Adrenergic, beta; D000450:Aldosterone; D012083:Renin; D008790:Metoprolol; D009638:Norepinephrine; D004837:Epinephrine